March 2016
Fever
Pain/ Inflammation
+ murphy's sign
Ceftriaxone 1g q 24h IV
Increased neutrophils
3. Impaired Digestion/Nutrition
Gallstone
Choledocholithiasis (common bile duct)
Nausea/Vomiting
Ondansetron 4mg q4h PRN IV
Cholangitis
NPO
Priority Assessments:
Pain, Vital Signs, RUQ distention,
Labs, I&O, signs of rupture or shock
4. Immobility
Pain
Nausea/Vomiting
Enoxaparin 40 mg daily SQ
BilirubinDirect=1.3
US &CT-> increased hepatic texture -> fatty liver
Pure Hypercholesterol
Impaired fasting glucose (gallstone
pancreatitis?)
Jennifer Kiaha-Raquino
Desired Outcomes
1. Pain (Biliary Colic)
-The patient will have pain controlled at an
acceptable level.
March 2016
Interventions
1. Pain (Biliary Colic)
-Educate patient of signs of increasing pain
and need to medicate prior to intolerable pain
level
-Educate patient on pain medication available
and times they can or will be given
-Administer medications promptly
-Educate patient on medication side effects
-Teach patient alternative pain management
techniques
-Keep environment calm with lights dimmed
-Position for comfort
2.Infection (Cholangitis)
2.Infection (Cholangitis)
-Infection will improve and sepsis will be
-Monitor vital signs closely, report changes
avoided.
promptly
-Administer antibiotic as prescribed
-Assess the need for and remove unnecessary
IV sites or other lines, tubes, or drains
-Use proper hand hygiene
-Teach patient proper hand hygiene
-Monitor WBC count
3. Impaired Digestion /Nutrition
3. Impaired Digestion /Nutrition
-Digestion and nutritional status will improve -Assess need for continued NPO status
with treatment
-Assess need for IVF therapy
-Monitor labs and weight
-Monitor vital signs
-Assess for nausea and vomiting
-Administer ondansetron as needed and
pantoprazole daily
4. Immobility
4. Immobility
-Mobility will increase with pain management -Prophylaxis enoxaparin will be given daily
and DVT will be prevented
-ICD will be used while in bed
-Encourage movement/mobility as tolerated
shortly after pain medication given
-Turn position q2h or sooner
5. Risk for Anxiety
5. Risk for Anxiety
-Anxiety levels will be controlled throughout -Educate patient on condition and relating
treatment
factors -Explain all procedures and treatments
to patient
-Seek additional support as needed
Jennifer Kiaha-Raquino
March 2016
Evaluation
-Pain will be measured q shift and as needed with a pain rating scale and a consistent decrease is
desired. Infection status/improvement will be measured by having vital signs WNL and lab
results WNL as well a decrease in pain and inflammation. Digestion and nutritional
status/improvement will be measured by lab results WNL as well as no nausea and vomiting.
Increasing mobility will be measured by observing patient up out of bed without pain. Anxiety
management will be measured by patient stating tolerable anxiety as well as understanding of
condition and treatments.
Jennifer Kiaha-Raquino
March 2016
References
Gulanick, M. & Myers, J. (2011). Nursing care plans diagnoses, interventions, and outcomes. St.
Louis, MO: Elsevier.
Ignatavicius, D.D. & Workman, M.L. (2013). Care of patients with problems of the biliary
system and pancreas. In Medical-surgical nursing patient-centered collaborative care.
St. Louis, MO: Elsevier.
Wilson, B., Shannon, M., Shields, K. (2013). Pearson nursess drug guide. Upper Saddle River,
NJ: Pearson.